Search

Asifa Habib

Examiner (ID: 14131, Phone: (571)270-7032 , Office: P/2887 )

Most Active Art Unit
2887
Art Unit(s)
2887, 2876
Total Applications
354
Issued Applications
240
Pending Applications
39
Abandoned Applications
75

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7436444 [patent_doc_number] => 20040266877 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-30 [patent_title] => 'Liquid pharmaceutical compositions comprising thyroid hormones' [patent_app_type] => new [patent_app_number] => 10/802659 [patent_app_country] => US [patent_app_date] => 2004-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2736 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20040266877.pdf [firstpage_image] =>[orig_patent_app_number] => 10802659 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/802659
Liquid pharmaceutical compositions comprising thyroid hormones Mar 14, 2004 Abandoned
Array ( [id] => 7297587 [patent_doc_number] => 20040214861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Compositions of a cyclooxygenase-2 selective inhibitors and 5-HT1B1D antagonists for the treatment and prevention of migraine' [patent_app_type] => new [patent_app_number] => 10/794041 [patent_app_country] => US [patent_app_date] => 2004-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20608 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0214/20040214861.pdf [firstpage_image] =>[orig_patent_app_number] => 10794041 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/794041
Compositions of a cyclooxygenase-2 selective inhibitors and 5-HT1B1D antagonists for the treatment and prevention of migraine Mar 4, 2004 Abandoned
Array ( [id] => 464460 [patent_doc_number] => 07238814 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-03 [patent_title] => 'Compositions of S-nitrosothiols and methods of use' [patent_app_type] => utility [patent_app_number] => 10/781705 [patent_app_country] => US [patent_app_date] => 2004-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17186 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/238/07238814.pdf [firstpage_image] =>[orig_patent_app_number] => 10781705 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/781705
Compositions of S-nitrosothiols and methods of use Feb 19, 2004 Issued
Array ( [id] => 7427034 [patent_doc_number] => 20040229854 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-18 [patent_title] => 'Immediate release dosage form for HRT' [patent_app_type] => new [patent_app_number] => 10/781493 [patent_app_country] => US [patent_app_date] => 2004-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4829 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0229/20040229854.pdf [firstpage_image] =>[orig_patent_app_number] => 10781493 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/781493
Immediate release dosage form for HRT Feb 17, 2004 Abandoned
Array ( [id] => 7151030 [patent_doc_number] => 20040171598 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Use of steroids to treat persons suffering from ocular disorders' [patent_app_type] => new [patent_app_number] => 10/771829 [patent_app_country] => US [patent_app_date] => 2004-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2904 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171598.pdf [firstpage_image] =>[orig_patent_app_number] => 10771829 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/771829
Use of steroids to treat persons suffering from ocular disorders Feb 3, 2004 Abandoned
Array ( [id] => 7424329 [patent_doc_number] => 20040208844 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-21 [patent_title] => 'Products and drug delivery vehicles' [patent_app_type] => new [patent_app_number] => 10/485023 [patent_app_country] => US [patent_app_date] => 2004-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9757 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20040208844.pdf [firstpage_image] =>[orig_patent_app_number] => 10485023 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/485023
Products and drug delivery vehicles Jan 27, 2004 Abandoned
Array ( [id] => 7336883 [patent_doc_number] => 20040132688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Plasma glucosylceramide deficiency as risk factor for thrombosis and modulator of anticoagulant protein C' [patent_app_type] => new [patent_app_number] => 10/739962 [patent_app_country] => US [patent_app_date] => 2003-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 17058 [patent_no_of_claims] => 90 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132688.pdf [firstpage_image] =>[orig_patent_app_number] => 10739962 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/739962
Plasma glucosylceramide deficiency as risk factor for thrombosis and modulator of anticoagulant protein C Dec 16, 2003 Abandoned
Array ( [id] => 7097179 [patent_doc_number] => 20050129637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Pigment dispersion for cosmetics, cosmetic compositions containing the same, and process for making such cosmetic compositions' [patent_app_type] => utility [patent_app_number] => 10/735670 [patent_app_country] => US [patent_app_date] => 2003-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3964 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20050129637.pdf [firstpage_image] =>[orig_patent_app_number] => 10735670 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/735670
Pigment dispersion for cosmetics, cosmetic compositions containing the same, and process for making such cosmetic compositions Dec 15, 2003 Abandoned
Array ( [id] => 7677201 [patent_doc_number] => 20040152625 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Method for improving the pharmacokinetics of an NNRTI' [patent_app_type] => new [patent_app_number] => 10/736301 [patent_app_country] => US [patent_app_date] => 2003-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4160 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152625.pdf [firstpage_image] =>[orig_patent_app_number] => 10736301 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/736301
Method for improving the pharmacokinetics of an NNRTI Dec 14, 2003 Abandoned
Array ( [id] => 7070094 [patent_doc_number] => 20050245479 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-03 [patent_title] => 'Myeloglycan' [patent_app_type] => utility [patent_app_number] => 10/726517 [patent_app_country] => US [patent_app_date] => 2003-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 9793 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20050245479.pdf [firstpage_image] =>[orig_patent_app_number] => 10726517 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/726517
Myeloglycan Dec 3, 2003 Abandoned
Array ( [id] => 7326139 [patent_doc_number] => 20040138464 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-15 [patent_title] => '2-Oxadiazolechromone derivatives' [patent_app_type] => new [patent_app_number] => 10/725346 [patent_app_country] => US [patent_app_date] => 2003-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14622 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20040138464.pdf [firstpage_image] =>[orig_patent_app_number] => 10725346 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/725346
2-oxadiazolechromone derivatives Dec 1, 2003 Issued
Array ( [id] => 7238523 [patent_doc_number] => 20040157802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Anti-microbial agents derived from methionine sulfoximine analogues' [patent_app_type] => new [patent_app_number] => 10/715679 [patent_app_country] => US [patent_app_date] => 2003-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9967 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20040157802.pdf [firstpage_image] =>[orig_patent_app_number] => 10715679 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/715679
Anti-microbial agents derived from methionine sulfoximine analogues Nov 16, 2003 Abandoned
Array ( [id] => 7157118 [patent_doc_number] => 20050027116 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Solid phase synthesis' [patent_app_type] => utility [patent_app_number] => 10/685331 [patent_app_country] => US [patent_app_date] => 2003-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5208 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20050027116.pdf [firstpage_image] =>[orig_patent_app_number] => 10685331 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/685331
Solid phase synthesis Oct 13, 2003 Abandoned
Array ( [id] => 7223963 [patent_doc_number] => 20050261207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Glucose-based compounds with affinity to p-selectin' [patent_app_type] => utility [patent_app_number] => 10/530601 [patent_app_country] => US [patent_app_date] => 2003-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6486 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20050261207.pdf [firstpage_image] =>[orig_patent_app_number] => 10530601 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/530601
Glucose-based compounds with affinity to P-selectin Oct 12, 2003 Issued
Array ( [id] => 7281286 [patent_doc_number] => 20040063663 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-01 [patent_title] => 'Acylated cyclodextrin: guest molecule inclusion complexes' [patent_app_type] => new [patent_app_number] => 10/675900 [patent_app_country] => US [patent_app_date] => 2003-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12666 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20040063663.pdf [firstpage_image] =>[orig_patent_app_number] => 10675900 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/675900
Acylated cyclodextrin: guest molecule inclusion complexes Sep 29, 2003 Abandoned
Array ( [id] => 7674688 [patent_doc_number] => 20040127430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Chiral monophosphorus compounds and their transition metal complexes' [patent_app_type] => new [patent_app_number] => 10/660150 [patent_app_country] => US [patent_app_date] => 2003-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6950 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127430.pdf [firstpage_image] =>[orig_patent_app_number] => 10660150 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/660150
Chiral monophosphorus compounds and their transition metal complexes Sep 10, 2003 Abandoned
Array ( [id] => 7306473 [patent_doc_number] => 20040116501 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Treatment of nonallergic rhinitis by selective phosphodiesterase 4 inhibitors' [patent_app_type] => new [patent_app_number] => 10/654365 [patent_app_country] => US [patent_app_date] => 2003-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4857 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20040116501.pdf [firstpage_image] =>[orig_patent_app_number] => 10654365 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/654365
Treatment of nonallergic rhinitis by selective phosphodiesterase 4 inhibitors Sep 2, 2003 Abandoned
Array ( [id] => 6739831 [patent_doc_number] => 20030157200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Use of oligosaccharides to stimulate beta-endorphin production' [patent_app_type] => new [patent_app_number] => 10/332136 [patent_app_country] => US [patent_app_date] => 2003-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4107 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157200.pdf [firstpage_image] =>[orig_patent_app_number] => 10332136 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/332136
Use of oligosaccharides to stimulate beta-endorphin production Jan 5, 2003 Abandoned
Array ( [id] => 6797518 [patent_doc_number] => 20030176392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Treatment of EBV and KHSV infection and associated abnormal cellular proliferation' [patent_app_type] => new [patent_app_number] => 10/326444 [patent_app_country] => US [patent_app_date] => 2002-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 42546 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176392.pdf [firstpage_image] =>[orig_patent_app_number] => 10326444 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/326444
Treatment of EBV and KHSV infection Dec 18, 2002 Issued
Array ( [id] => 7097172 [patent_doc_number] => 20050129630 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Utilization of natural pigments from lichens, cyanobacteria, fungi and plants for sun protection' [patent_app_type] => utility [patent_app_number] => 10/488426 [patent_app_country] => US [patent_app_date] => 2002-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 6111 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20050129630.pdf [firstpage_image] =>[orig_patent_app_number] => 10488426 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/488426
Utilization of natural pigments from lichens, cyanobacteria, fungi and plants for sun protection Sep 2, 2002 Abandoned
Menu